Capricor Soars After Cantor Upgrade as FDA Path for Deramiocel Becomes Clearer
Analyst upgrade sends Capricor shares higher after company outlines BLA amendment path for deramiocel focused on upper-limb function.
NOTRELOAD AI
Valneva’s Lyme Disease Vaccine Candidate Clears Key EMA Hurdle
Valneva shares surge after EMA validates its Lyme disease vaccine candidate developed with Pfizer. Phase 3 trial showed over 70% efficacy.
York Space Systems Stock Plunges After Slashing 2026 Revenue Guidance
York Space Systems reports Q2 revenue of $92.5M (+10% YoY) and a net loss of $0.31/share. Full-year 2026 guidance lowered to $375–$405M due to IDIQ procurement shift.
Applied Materials Beats Estimates, but Shares Still Slip Amid Sky-High Expectations
Applied Materials posted record $9.12B Q3 revenue up 25% YoY, beating estimates, with Q4 guidance above consensus driven by AI demand in DRAM and packaging.
Ondas Shares Fall Despite Record Revenue as Wider Losses Overshadow Growth
Ondas reports record $83.8M Q2 revenue and raises 2026 guidance, but larger losses and elevated spending create mixed results amid growth investments.
Silver Lake Eyes Workday in One of the Biggest Software Takeovers Ever
Talks are ongoing as Workday shares fall amid AI concerns.